The Role of Salvage Radical Prostatectomy in Patients with Radiation-Resistant Prostate Cancer

被引:3
|
作者
Drobner, Jake [1 ,2 ]
Kaldany, Alain [1 ,2 ]
Shah, Mihir S. [3 ]
Ghodoussipour, Saum [1 ,2 ]
机构
[1] Rutgers Canc Inst New Jersey, Div Urol Oncol, New Brunswick, NJ 08901 USA
[2] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA
[3] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Urol, Philadelphia, PA 19107 USA
关键词
prostate cancer; salvage therapy; salvage prostatectomy; post-radiation prostatectomy; post-radiation recurrence; biochemical recurrence; radiation-resistant prostate cancer; SEMINAL-VESICLE INVOLVEMENT; FUNCTIONAL OUTCOMES; THERAPY; SURGERY; COMPLICATIONS; RADIOTHERAPY; PREDICTORS; RECURRENCE; GUIDELINES; FAILURE;
D O I
10.3390/cancers15143734
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Prostate cancer affects one out of every eight men over the course of their lifetimes, and recurrence of the disease after initial cancer treatment occurs in almost one-third of men. The aim of our review was to assess the role of salvage radical prostatectomy in patients with prostate cancer recurrence after initial treatment with radiotherapy. Outcome data demonstrate that radical prostatectomy has oncologic benefits, although it incurs several intraoperative and postoperative functional risks including rectal injury, erectile dysfunction, and incontinence. Given that there is no clinical consensus on which management approach is superior for patients with localized prostate cancer recurrence, this review provides evidence that radical prostatectomy offers meaningful cancer control and should be considered for select patients with radiation-resistant disease. There are multiple treatment strategies for patients with localized prostate adenocarcinoma. In intermediate- and high-risk patients, external beam radiation therapy demonstrates effective long-term cancer control rates comparable to radical prostatectomy. In patients who opt for initial radiotherapy but have a local recurrence of their cancer, there is no unanimity on the optimal salvage approach. The lack of randomized trials comparing surgery to other local salvage therapy or observation makes it difficult to ascertain the ideal management. A narrative review of existing prospective and retrospective data related to salvage radical prostatectomy after radiation therapy was undertaken. Based on retrospective and prospective data, post-radiation salvage radical prostatectomy confers oncologic benefits, with overall survival ranging from 84 to 95% at 5 years and from 52 to 77% at 10 years. Functional morbidity after salvage prostatectomy remains high, with rates of post-surgical incontinence and erectile dysfunction ranging from 21 to 93% and 28 to 100%, respectively. Factors associated with poor outcomes after post-radiation salvage prostatectomy include preoperative PSA, the Gleason score, post-prostatectomy staging, and nodal involvement. Salvage radical prostatectomy represents an effective treatment option for patients with biochemical recurrence after radiotherapy, although careful patient selection is important to optimize oncologic and functional outcomes.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] The role of lymph node dissection in salvage radical prostatectomy for patients with radiation recurrent prostate cancer
    Quhal, Fahad
    Rajwa, Pawel
    Mori, Keiic
    Laukhtina, Ekaterina
    Grossmann, Nico
    Schuettfort, Victor M.
    Koenig, Frederik
    Aydh, Abdulmajeed
    Motlagh, Reza S.
    Katayama, Satoshi
    Mostafai, Hadi
    Pradere, Benjamin
    Marra, Giancarlo
    Gontero, Paolo
    Mathieu, Romain
    Karakiewicz, Pierre I.
    Briganti, Alberto
    Shariat, Shahrokh F.
    Heidenreich, Axel
    [J]. PROSTATE, 2021, 81 (11): : 765 - 771
  • [2] Perineal salvage prostatectomy for radiation resistant prostate cancer
    van der Poel, Henk G.
    Beetsma, Daan B.
    van Boven, Hester
    Horenblas, Simon
    [J]. EUROPEAN UROLOGY, 2007, 51 (06) : 1565 - 1572
  • [3] Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy
    Stephenson, AJ
    Eastham, JA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (32) : 8198 - 8203
  • [4] The role of lymph node dissection in patients undergoing salvage radical prostatectomy for radiation recurrent prostate cancer
    Quhal, F.
    Rajwa, P.
    Laukhtina, E.
    Mostafai, H.
    Pradere, B.
    Gontero, P.
    Mathieu, R.
    Briganti, A.
    Heidenreich, A.
    Shariat, S. F.
    [J]. EUROPEAN UROLOGY, 2022, 81 : S1421 - S1422
  • [5] Salvage Radical Prostatectomy in Nonmetastatic Castration-Resistant Prostate Cancer
    Lopez-Fontana, Gaston
    Manuel Guglielmi, Juan
    Lopez-Fontana, Rodrigo
    Lis Hinojosa-Jury, Mariana
    Lopez-Fontana, Constanza
    Daniel Lopez-Laur, Jose
    [J]. ARCHIVOS ESPANOLES DE UROLOGIA, 2022, 75 (07): : 638 - 641
  • [6] Salvage external beam radiation after radical prostatectomy for prostate cancer
    Miercort, CR
    Lee, RJ
    Middleton, A
    Sause, WT
    [J]. CANCER JOURNAL, 2002, 8 (06): : 505 - 505
  • [7] Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy
    Leonardo, Costantino
    Simone, Giuseppe
    Papalia, Rocco
    Franco, Giorgio
    Guaglianone, Salvatore
    Gallucci, Michele
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (06) : 584 - 586
  • [8] Salvage radical prostatectomy for recurrence of prostate cancer after radiation therapy
    James A. Eastham
    Christopher J. DiBlasio
    Peter T. Scardino
    [J]. Current Urology Reports, 2003, 4 (3) : 211 - 215
  • [9] Robotic Assisted Laparoscopic Salvage Prostatectomy for Radiation Resistant Prostate Cancer
    Eandi, Jonathan A.
    Link, Brian A.
    Nelson, Rebecca A.
    Josephson, David Y.
    Lau, Clayton
    Kawachi, Mark H.
    Wilson, Timothy G.
    [J]. JOURNAL OF UROLOGY, 2010, 183 (01): : 133 - 137
  • [10] Salvage radiation therapy for prostate cancer patients after prostatectomy
    Mima, Takashi
    Ohori, Makoto
    Hirasawa, Yosuke
    Mikami, Ryuji
    Arai, Ayako
    Hashimoto, Takeshi
    Satake, Naoya
    Gondo, Tatsuo
    Nakagami, Yoshihiro
    Namiki, Kazunori
    Tokuuye, Koichi
    Ohno, Yoshio
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (03) : 281 - 286